Cell-Permeable NM23 Blocks the Maintenance and Progression of Established Pulmonary Metastasis

Overview of attention for article published in Cancer Research, November 2011

Altmetric Badge

Retracted

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs: 1 blog
patent: 10 patents

peer_reviews: 1 peer review site

Readers on

mendeley: 33 Mendeley

So far, Altmetric has seen 10 patents that reference this research output.

Pharmaceutical composition, containing NM23 activator, for inhibiting cancer metastasis

Grant US-11389411-B2

United States of America

19 Jul 2022

METHOD FOR ENHANCING TUMOR GROWTH

Application US-20220193270-A1

United States of America

23 Jun 2022

PHARMACEUTICAL COMPOSITION, CONTAINING NM23 ACTIVATOR, FOR INHIBITING CANCER METASTASIS

Application WO-2018199727-A1

World Intellectual Property Organisation (WIPO)

01 Nov 2018

CELL-PERMEABLE (CP)-Cas9 RECOMBINANT PROTEIN AND USES THEREOF

Application WO-2018062866-A2

World Intellectual Property Organisation (WIPO)

05 Apr 2018

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 6 additional patents.